‘300-400 Mn Vaccine Doses By Dec'

Serum Institute of India CEO Adar Poonawalla talks about vaccine trials at Oxford

- 

With the trials of Covid-19 vaccine being developed by AstraZeneca and Oxford University showing encouraging results, Adar Poonawalla of the Serum Institute of India (SII) has said at least 300 million doses of the potential vaccine will be ready by December.

In an exclusive interview to India Today TV News Director Rahul Kanwal on Tuesday, SII Chief Executive Officer Poonawalla said 300-400 million doses of the potential vaccine ‘Covishield’ will be ready by December.

Each dose has 10 vials, the SII CEO added.

“Covishield is going to be the first Covid-19 vaccine we hope to launch if trials are successful in the UK and India,” Poonawalla told India Today. He added that they expect the vaccine to reach the people of India in large numbers by the first quarter of 2021.

Poonawalla also added that the vaccine will cost around ₹1,000 in India.